Comparison · NSE · data 2026-11-02
QVC Exports Limited vs Saroja Pharma Industries India Ltd.
In plain words
Size: QVC Exports Limited is about 1.6 times the market value of Saroja Pharma Industries India Ltd..
Valuation (P/E): Saroja Pharma Industries India Ltd. 9.7 vs QVC Exports Limited 7.6.
Return on equity: Saroja Pharma Industries India Ltd. 9.8% vs QVC Exports Limited 4.9%.
Profit growth over 3 years: Saroja Pharma Industries India Ltd. 15% a year vs QVC Exports Limited 8.1% a year.
Debt to equity: QVC Exports Limited 1.06 vs Saroja Pharma Industries India Ltd. 0.83.
Differences in the numbers, not a recommendation of either stock.
Side by side
| QVCEL | SAROJA | |
|---|---|---|
| Price | ₹24.15 | ₹38.8 |
| Market cap | ₹25 cr | ₹16 cr |
| P/E | 7.6 | 9.7 |
| P/B | — | 0.9 |
| ROE | 4.9% | 9.8% |
| ROCE | 7.9% | 17.9% |
| Debt / equity | 1.06 | 0.83 |
| Operating margin | 1.1% | 5.7% |
| Dividend yield | 4.14% | 0.00% |
| Sales growth, 3 years (yearly) | 28.6% | 11.8% |
| Profit growth, 3 years (yearly) | 8.1% | 15.0% |
| 1-year return | -24.5% | -11.1% |
| Revenue, last 12 months | ₹440 cr | ₹71 cr |
| Net profit, last 12 months | ₹4 cr | ₹2 cr |
| Latest quarter | — | — |
| Quarter net profit | — | — |
| Quarter profit vs a year earlier | — | — |
| Promoter holding | — | — |
| Health check | Average (5.9/10) | Strong (7.2/10) |
Common questions
Which has a higher P/E, QVC Exports Limited or Saroja Pharma Industries India Ltd.?
Saroja Pharma Industries India Ltd. trades at the higher P/E (9.7 against 7.6). A higher P/E means the market pays more for each rupee of past earnings; on its own it does not say which is better.
Which earns a higher return on equity?
Saroja Pharma Industries India Ltd. (9.8% against 4.9%).
Which carries more debt?
QVC Exports Limited has the higher debt-to-equity ratio (1.06 against 0.83).